Hunan Er-Kang Pharmaceutical Co., Ltd's (SZSE:300267) Top Holders Are Insiders and They Are Likely Disappointed by the Recent 11% Drop

Simply Wall StDec 27, 2024 01:51 ET

Hunan Er-Kang Pharmaceutical (SZSE:300267 Shareholders Incur Further Losses as Stock Declines 6.6% This Week, Taking Five-year Losses to 55%

Simply Wall StNov 4, 2024 00:39 ET

Hunan Er-Kang Pharmaceutical Co., Ltd's (SZSE:300267) Market Cap Increased by CN¥371m, Insiders Receive a 45% Cut

Simply Wall StSep 25, 2024 23:58 ET

Hunan Er-Kang Pharmaceutical Co., Ltd's (SZSE:300267) 28% Share Price Surge Not Quite Adding Up

Simply Wall StAug 8, 2024 18:47 ET

The Recent Pullback Must Have Dismayed Hunan Er-Kang Pharmaceutical Co., Ltd (SZSE:300267) Insiders Who Own 45% of the Company

Simply Wall StJun 3, 2024 19:30 ET

Investors in Hunan Er-Kang Pharmaceutical (SZSE:300267) From Five Years Ago Are Still Down 54%, Even After 7.5% Gain This Past Week

Simply Wall StMay 1, 2024 18:50 ET